Attune Neurosciences
Seed
Attune Neurosciences: Creating non-invasive neurostimulation devices for improved sleep health.
Founded
2019Attune Neurosciences: Creating non-invasive neurostimulation devices for improved sleep health.
Attune Neurosciences, founded with a mission to enhance human health and performance, is a clinical-stage medical device company specializing in non-invasive neurostimulation products. Their primary focus is on addressing sleep- and wake-related conditions, aiming to support patients, government entities, and industrial applications. By leveraging cutting-edge technology, Attune Neurosciences seeks to provide clinically proven solutions that improve overall well-being.
Notable investors include leading venture capital firms, the National Institutes of Health, the US Special Operations Command (SOCOM), and the US Air Force. These affiliations underscore the company's credibility and potential impact. Attune Neurosciences has achieved significant milestones in developing its innovative medical devices, contributing to advancements in non-invasive neurostimulation therapies. The company's work holds promise for substantial improvements in sleep health and related areas, reflecting its commitment to enhancing quality of life through advanced medical technology.
Companies similar to Attune Neurosciences include Actipulse Neuroscience, Scion Neurostim, neusleep and Nia Therapeutics.
Attune Neurosciences was founded in 2019.
Attune Neurosciences' headquarters is located in Menlo Park, CA, US.
Attune Neurosciences' most recent funding round was for $3.8M (USD) in April 2021.
As of Apr 15, 2021, Attune Neurosciences has raised a total of $3.8M (USD).
Attune Neurosciences has 14 employees as of Feb 5, 2024.
neusleep
neusleep.co
